Schizoaffective Disorders Completed Phase 4 Trials for Armodafinil (DB06413)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00373672Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective DisorderTreatment